If any controlled substance appears in the listed bulk database, please ignore it, as we do not supply or offer controlled substances.
Cobimetinib-D8
100% accuracy
of data
24/7 scientific
support
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Cobimetinib-D8

● In Stock

Catalogue No.:DVE001653
CAS No.:N/A
Mol. Formula:C21H13D8F3IN3O2
Mol. Weight:539.37 g/mol

Additional information on Cobimetinib-D8

Parent drug

Cobimetinib

IUPAC Name

(S)-(3, 4-Difluoro-2-((2-fluoro-4-iodophenyl)amino)phenyl)(3-hydroxy-3-(piperidin-2-yl-3, 3, 4, 4, 5, 5, 6, 6-d8)azetidin-1-yl)methanone

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Smiles

O=C(C1=CC=C(F)C(F)=C1NC2=CC=C(I)C=C2F)N3CC([C@H]4NC([2H])([2H])C([2H])([2H])C([2H])([2H])C4([2H])[2H])(O)C3

Description

Cobimetinib-D8 is a deuterium-labeled analog of Cobimetinib commonly utilized as an internal standard in analytical and pharmacokinetic research. This stable isotope-labeled compound improves the accuracy of mass spectrometry and liquid chromatography enabling precise quantification of Cobimetinib in biological samples. Ideal for researchers and laboratories Cobimetinib-D8 ensures reliable analysis in therapeutic drug monitoring pharmacokinetic studies and metabolic research.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
Products quotation
Name
Url
 
This field is hidden when viewing the form
This field is hidden when viewing the form